InfuSystem Holdings, Inc.
AMEX:INFU · New York Stock Exchange American
+$0.09 today
Vol 0.16M · Avg 0.16M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Stock Ticker Earnings Waterfall
AMEX:INFU · Revenue to Net Income
Key Ratios
Analysis
$142.4M of revenue converted into $7.9M of net income for the selected period. Gross margin is 56.8% and net margin is 5.5%, showing how much revenue survives after costs and taxes. EPS is $0.38, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $143.4M +6.4% | $134.9M +7.2% | $125.8M +14.4% | $109.9M +7.4% | $102.4M | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $63.1M -2.0% | $64.5M +2.8% | $62.7M +27.0% | $49.4M +12.6% | $43.8M | $725.6M | $804.0M | $882.4M |
| Gross Profit | $80.3M +14.1% | $70.4M +11.6% | $63.1M +4.2% | $60.6M +3.5% | $58.5M | $8.9B | $7.6B | $6.2B |
| Gross Margin | 56.0% +3.8pp | 52.2% +2.0pp | 50.2% -4.9pp | 55.1% -2.1pp | 57.2% | 9.8% | 28.9% | 38.3% |
| Research & Development | $0 | $0 | $0 | $0 | $0 | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $67.5M +7.9% | $62.5M +7.7% | $58.0M +2.9% | $56.4M +9.6% | $51.5M | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $68.4M +7.7% | $63.5M +7.6% | $59.0M +0.2% | $58.9M +5.7% | $55.7M | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $13.3M +6.4% | $12.5M -0.1% | $12.5M -6.4% | $13.4M -8.6% | $14.6M | $374.2M | $1.2B | $631.8M |
| EBITDA | $25.2M +25.9% | $20.0M +21.2% | $16.5M +11.0% | $14.9M -13.7% | $17.3M | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | 17.6% +2.7pp | 14.9% +1.7pp | 13.1% -0.4pp | 13.5% -3.3pp | 16.9% | 5.6% | 46.3% | 42.0% |
| Operating Income | $11.9M +73.0% | $6.9M +68.6% | $4.1M +147.2% | $1.7M -41.3% | $2.8M | $12.3B | $14.0B | -$15.7B |
| Operating Margin | 8.3% +3.2pp | 5.1% +1.9pp | 3.2% +1.7pp | 1.5% -1.2pp | 2.8% | 16.6% | 24.1% | 22.0% |
| Interest Income | $0 | $0 | $0 | $0 | $0 | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $1.3M -26.9% | $1.8M -18.1% | $2.2M +54.8% | $1.4M +1.8% | $1.4M | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$1.3M +29.2% | -$1.8M +18.1% | -$2.2M -46.8% | -$1.5M +2.5% | -$1.6M | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | $10.6M +110.0% | $5.1M +173.3% | $1.9M +1323.8% | $130.0K -89.7% | $1.3M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | 7.4% +3.7pp | 3.8% +2.3pp | 1.5% +1.4pp | 0.1% -1.1pp | 1.2% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $4.0M +47.2% | $2.7M +177.2% | $979.0K +774.1% | $112.0K +168.7% | -$163.0K | $1.3B | -$1.6B | $745.2M |
| Net Income | $6.6M +182.6% | $2.3M +168.9% | $872.0K +4744.4% | $18.0K -98.7% | $1.4M | $4.9B | $4.8B | $4.7B |
| Net Margin | 4.6% +2.9pp | 1.7% +1.0pp | 0.7% +0.7pp | 0.0% -1.4pp | 1.4% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | $0 +190.9% | $0 +175.0% | $0 +4344.4% | $0 -98.7% | $0 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | $0 +181.8% | $0 +175.0% | $0 +4900.0% | $0 -98.7% | $0 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $20.7M -2.9% | $21.3M +1.2% | $21.0M +1.8% | $20.6M +0.6% | $20.5M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $21.1M -2.8% | $21.7M +0.3% | $21.6M +0.5% | $21.5M -2.3% | $22.0M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Electromed, Inc.
AMEX:ELMD
$307.52M
OraSure Technologies, Inc.
NASDAQ:OSUR
$287.79M
Orchestra BioMed Holdings, Inc.
NASDAQ:OBIO
$245.51M
Utah Medical Products, Inc.
NASDAQ:UTMD
$216.00M
Inventiva S.A.
NASDAQ:IVA
$200.13M
KORU Medical Systems, Inc.
NASDAQ:KRMD
$183.73M
Stereotaxis, Inc.
AMEX:STXS
$179.84M
Nano-X Imaging Ltd.
NASDAQ:NNOX
$122.48M
Solana Company
NASDAQ:HSDT
$89.92M
Nyxoah S.A.
NASDAQ:NYXH
$55.05M
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does INFU generate?
InfuSystem Holdings, Inc. (INFU) reported $143.44M of revenue in fiscal 2025.
Is INFU profitable?
InfuSystem Holdings, Inc. (INFU) reported $6.63M of net income, with a net margin of 4.6%.
Explore More
Continue the stock analysis
Jump to another research area for this company.